APO Research
Talk to an analyst

APO RESEARCH · REPORT

Midostaurin Soft Capsules

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Midostaurin Soft Capsules Industry Growth and Trends Forecast to 2032

27 December 202599 pages

Choose your research edition.

Industry ResearchMidostaurin Soft Capsules Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Midostaurin Soft Capsules Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Midostaurin Soft Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Midostaurin Soft Capsules Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Midostaurin Soft Capsules Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Midostaurin Soft Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Midostaurin Soft Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Midostaurin Soft Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Midostaurin Soft Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Midostaurin Soft Capsules include Dr Reddys Laboratories, Glenmark Pharmaceuticals, Zydus, Novartis and Teva Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Midostaurin Soft Capsules market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Midostaurin Soft Capsules market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Midostaurin Soft Capsules market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Midostaurin Soft Capsules.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Midostaurin Soft Capsules market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Midostaurin Soft Capsules Market by Company

Dr Reddys Laboratories

Glenmark Pharmaceuticals

Zydus

Novartis

Teva Pharmaceuticals

Midostaurin Soft Capsules Segment by Type

Original Drug

Generic Drug

Midostaurin Soft Capsules Segment by Application

Systemic Mastocytosis

Acute Myeloid Leukemia

Other

Midostaurin Soft Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Midostaurin Soft Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Midostaurin Soft Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Midostaurin Soft Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Midostaurin Soft Capsules manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Midostaurin Soft Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Original Drug Table 2. Major Company of Generic Drug Table 3. Global Midostaurin Soft Capsules Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Midostaurin Soft Capsules Sales by Type (2021-2026) & (K Units) Table 5. Global Midostaurin Soft Capsules Sales Market Share in Volume by Type (2021-2026) Table 6. Global Midostaurin Soft Capsules Sales by Type (2021-2026) & (US$ Million) Table 7. Global Midostaurin Soft Capsules Sales Market Share in Value by Type (2021-2026) Table 8. Global Midostaurin Soft Capsules Price by Type (2021-2026) & (US$/Unit) Table 9. Global Midostaurin Soft Capsules Sales by Type (2027-2032) & (K Units) Table 10. Global Midostaurin Soft Capsules Sales Market Share in Volume by Type (2027-2032) Table 11. Global Midostaurin Soft Capsules Sales by Type (2027-2032) & (US$ Million) Table 12. Global Midostaurin Soft Capsules Sales Market Share in Value by Type (2027-2032) Table 13. Global Midostaurin Soft Capsules Price by Type (2027-2032) & (US$/Unit) Table 14. North America Midostaurin Soft Capsules Sales by Type (2021-2026) & (K Units) Table 15. North America Midostaurin Soft Capsules Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Midostaurin Soft Capsules Sales by Type (2021-2026) & (K Units) Table 17. Europe Midostaurin Soft Capsules Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Midostaurin Soft Capsules Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Midostaurin Soft Capsules Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Midostaurin Soft Capsules Sales by Type (2021-2026) & (K Units) Table 21. Latin America Midostaurin Soft Capsules Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Midostaurin Soft Capsules Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Midostaurin Soft Capsules Sales by Type (2021-2026) & (US$ Million) Table 24. Midostaurin Soft Capsules Industry Trends Table 25. Midostaurin Soft Capsules Industry Drivers Table 26. Midostaurin Soft Capsules Industry Opportunities and Challenges Table 27. Midostaurin Soft Capsules Industry Restraints Table 28. Global Midostaurin Soft Capsules Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Midostaurin Soft Capsules Revenue Market Share by Company (2021-2026) Table 30. Global Midostaurin Soft Capsules Sales by Company (2021-2026) & (K Units) Table 31. Global Midostaurin Soft Capsules Sales Share by Company (2021-2026) Table 32. Global Midostaurin Soft Capsules Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Midostaurin Soft Capsules Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Midostaurin Soft Capsules Major Company Production Sites and Headquarters Table 35. Global Midostaurin Soft Capsules Company, Product Type & Application Table 36. Global Midostaurin Soft Capsules Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Midostaurin Soft Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Midostaurin Soft Capsules Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Midostaurin Soft Capsules Sales by Region (2021-2026) & (K Units) Table 41. Global Midostaurin Soft Capsules Sales Market Share in Volume by Region (2021-2026) Table 42. Global Midostaurin Soft Capsules Sales by Region (2021-2026) & (US$ Million) Table 43. Global Midostaurin Soft Capsules Sales Market Share in Value by Region (2021-2026) Table 44. Global Midostaurin Soft Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Midostaurin Soft Capsules Sales by Region (2027-2032) & (K Units) Table 46. Global Midostaurin Soft Capsules Sales Market Share in Volume by Region (2027-2032) Table 47. Global Midostaurin Soft Capsules Sales by Region (2027-2032) & (US$ Million) Table 48. Global Midostaurin Soft Capsules Sales Market Share in Value by Region (2027-2032) Table 49. Global Midostaurin Soft Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Midostaurin Soft Capsules Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Midostaurin Soft Capsules Sales by Application (2021-2026) & (K Units) Table 52. Global Midostaurin Soft Capsules Sales Market Share in Volume by Application (2021-2026) Table 53. Global Midostaurin Soft Capsules Sales by Application (2021-2026) & (US$ Million) Table 54. Global Midostaurin Soft Capsules Sales Market Share in Value by Application (2021-2026) Table 55. Global Midostaurin Soft Capsules Price by Application (2021-2026) & (US$/Unit) Table 56. Global Midostaurin Soft Capsules Sales by Application (2027-2032) & (K Units) Table 57. Global Midostaurin Soft Capsules Sales Market Share in Volume by Application (2027-2032) Table 58. Global Midostaurin Soft Capsules Sales by Application (2027-2032) & (US$ Million) Table 59. Global Midostaurin Soft Capsules Sales Market Share in Value by Application (2027-2032) Table 60. Global Midostaurin Soft Capsules Price by Application (2027-2032) & (US$/Unit) Table 61. North America Midostaurin Soft Capsules Sales by Application (2021-2026) & (K Units) Table 62. North America Midostaurin Soft Capsules Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Midostaurin Soft Capsules Sales by Application (2021-2026) & (K Units) Table 64. Europe Midostaurin Soft Capsules Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Midostaurin Soft Capsules Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Midostaurin Soft Capsules Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Midostaurin Soft Capsules Sales by Application (2021-2026) & (K Units) Table 68. Latin America Midostaurin Soft Capsules Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Midostaurin Soft Capsules Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Midostaurin Soft Capsules Sales by Application (2021-2026) & (US$ Million) Table 71. Dr Reddys Laboratories Company Information Table 72. Dr Reddys Laboratories Business Overview Table 73. Dr Reddys Laboratories Midostaurin Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Dr Reddys Laboratories Midostaurin Soft Capsules Product Portfolio Table 75. Dr Reddys Laboratories Recent Development Table 76. Glenmark Pharmaceuticals Company Information Table 77. Glenmark Pharmaceuticals Business Overview Table 78. Glenmark Pharmaceuticals Midostaurin Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Glenmark Pharmaceuticals Midostaurin Soft Capsules Product Portfolio Table 80. Glenmark Pharmaceuticals Recent Development Table 81. Zydus Company Information Table 82. Zydus Business Overview Table 83. Zydus Midostaurin Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Zydus Midostaurin Soft Capsules Product Portfolio Table 85. Zydus Recent Development Table 86. Novartis Company Information Table 87. Novartis Business Overview Table 88. Novartis Midostaurin Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Novartis Midostaurin Soft Capsules Product Portfolio Table 90. Novartis Recent Development Table 91. Teva Pharmaceuticals Company Information Table 92. Teva Pharmaceuticals Business Overview Table 93. Teva Pharmaceuticals Midostaurin Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Teva Pharmaceuticals Midostaurin Soft Capsules Product Portfolio Table 95. Teva Pharmaceuticals Recent Development Table 96. North America Midostaurin Soft Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 97. North America Midostaurin Soft Capsules Sales by Country (2021-2026) & (K Units) Table 98. North America Midostaurin Soft Capsules Sales Market Share by Country (2021-2026) Table 99. North America Midostaurin Soft Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 100. North America Midostaurin Soft Capsules Sales Market Share Forecast by Country (2027-2032) Table 101. North America Midostaurin Soft Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. North America Midostaurin Soft Capsules Market Size by Country (2021-2026) & (US$ Million) Table 103. North America Midostaurin Soft Capsules Market Share by Country (2021-2026) Table 104. North America Midostaurin Soft Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. North America Midostaurin Soft Capsules Market Share Forecast by Country (2027-2032) Table 106. Europe Midostaurin Soft Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. Europe Midostaurin Soft Capsules Sales by Country (2021-2026) & (K Units) Table 108. Europe Midostaurin Soft Capsules Sales Market Share by Country (2021-2026) Table 109. Europe Midostaurin Soft Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 110. Europe Midostaurin Soft Capsules Sales Market Share Forecast by Country (2027-2032) Table 111. Europe Midostaurin Soft Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Europe Midostaurin Soft Capsules Market Size by Country (2021-2026) & (US$ Million) Table 113. Europe Midostaurin Soft Capsules Market Share by Country (2021-2026) Table 114. Europe Midostaurin Soft Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Europe Midostaurin Soft Capsules Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Midostaurin Soft Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Midostaurin Soft Capsules Sales by Country (2021-2026) & (K Units) Table 118. Asia-Pacific Midostaurin Soft Capsules Sales Market Share by Country (2021-2026) Table 119. Asia-Pacific Midostaurin Soft Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 120. Asia-Pacific Midostaurin Soft Capsules Sales Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Midostaurin Soft Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Midostaurin Soft Capsules Market Size by Country (2021-2026) & (US$ Million) Table 123. Asia-Pacific Midostaurin Soft Capsules Market Share by Country (2021-2026) Table 124. Asia-Pacific Midostaurin Soft Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Asia-Pacific Midostaurin Soft Capsules Market Share Forecast by Country (2027-2032) Table 126. Latin America Midostaurin Soft Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Latin America Midostaurin Soft Capsules Sales by Country (2021-2026) & (K Units) Table 128. Latin America Midostaurin Soft Capsules Sales Market Share by Country (2021-2026) Table 129. Latin America Midostaurin Soft Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 130. Latin America Midostaurin Soft Capsules Sales Market Share Forecast by Country (2027-2032) Table 131. Latin America Midostaurin Soft Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Latin America Midostaurin Soft Capsules Market Size by Country (2021-2026) & (US$ Million) Table 133. Latin America Midostaurin Soft Capsules Market Share by Country (2021-2026) Table 134. Latin America Midostaurin Soft Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Latin America Midostaurin Soft Capsules Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Midostaurin Soft Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Midostaurin Soft Capsules Sales by Country (2021-2026) & (K Units) Table 138. Middle East and Africa Midostaurin Soft Capsules Sales Market Share by Country (2021-2026) Table 139. Middle East and Africa Midostaurin Soft Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 140. Middle East and Africa Midostaurin Soft Capsules Sales Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Midostaurin Soft Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Midostaurin Soft Capsules Market Size by Country (2021-2026) & (US$ Million) Table 143. Middle East and Africa Midostaurin Soft Capsules Market Share by Country (2021-2026) Table 144. Middle East and Africa Midostaurin Soft Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Middle East and Africa Midostaurin Soft Capsules Market Share Forecast by Country (2027-2032) Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Midostaurin Soft Capsules Distributors List Table 149. Midostaurin Soft Capsules Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Midostaurin Soft Capsules Image Figure 2. Global Midostaurin Soft Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Midostaurin Soft Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Midostaurin Soft Capsules Sales (2021-2032) & (K Units) Figure 5. Original Drug Image Figure 6. Global Original Drug Sales YoY Growth (2021-2032) & (K Units) Figure 7. Generic Drug Image Figure 8. Global Generic Drug Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Midostaurin Soft Capsules Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Midostaurin Soft Capsules Market Share by Type 2025 VS 2032 Figure 11. North America Midostaurin Soft Capsules Sales Market Share in Volume by Type in 2025 Figure 12. North America Midostaurin Soft Capsules Sales Market Share in Value by Type in 2025 Figure 13. Europe Midostaurin Soft Capsules Sales Market Share in Volume by Type in 2025 Figure 14. Europe Midostaurin Soft Capsules Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Midostaurin Soft Capsules Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Midostaurin Soft Capsules Sales Market Share in Value by Type in 2025 Figure 17. Latin America Midostaurin Soft Capsules Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Midostaurin Soft Capsules Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Midostaurin Soft Capsules Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Midostaurin Soft Capsules Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Midostaurin Soft Capsules Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Systemic Mastocytosis Image Figure 24. Global Systemic Mastocytosis Sales YoY Growth (2021-2032) & (K Units) Figure 25. Acute Myeloid Leukemia Image Figure 26. Global Acute Myeloid Leukemia Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Midostaurin Soft Capsules Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Midostaurin Soft Capsules Market Share by Application 2025 VS 2032 Figure 31. North America Midostaurin Soft Capsules Sales Market Share in Volume by Application in 2025 Figure 32. North America Midostaurin Soft Capsules Sales Market Share in Value by Application in 2025 Figure 33. Europe Midostaurin Soft Capsules Sales Market Share in Volume by Application in 2025 Figure 34. Europe Midostaurin Soft Capsules Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Midostaurin Soft Capsules Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Midostaurin Soft Capsules Sales Market Share in Value by Application in 2025 Figure 37. Latin America Midostaurin Soft Capsules Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Midostaurin Soft Capsules Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Midostaurin Soft Capsules Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Midostaurin Soft Capsules Sales Market Share in Value by Application in 2025 Figure 41. North America Midostaurin Soft Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Midostaurin Soft Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Midostaurin Soft Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Midostaurin Soft Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Midostaurin Soft Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Midostaurin Soft Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Midostaurin Soft Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Midostaurin Soft Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Midostaurin Soft Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Midostaurin Soft Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Midostaurin Soft Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Midostaurin Soft Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Midostaurin Soft Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Midostaurin Soft Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Midostaurin Soft Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Midostaurin Soft Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Midostaurin Soft Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Midostaurin Soft Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Midostaurin Soft Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Midostaurin Soft Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Midostaurin Soft Capsules Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Midostaurin Soft Capsules Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Systemic Mastocytosis
  • Acute Myeloid Leukemia
  • Other
Companies covered
  • Dr Reddys Laboratories
  • Glenmark Pharmaceuticals
  • Zydus
  • Novartis
  • Teva Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Midostaurin Soft Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Midostaurin Soft Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Midostaurin Soft Capsules Market by Type
  6. 1.3.1 Original Drug
  7. 1.3.2 Generic Drug
  8. 1.4 Global Midostaurin Soft Capsules Market Size by Type
  9. 1.4.1 Global Midostaurin Soft Capsules Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Midostaurin Soft Capsules Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Midostaurin Soft Capsules Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Midostaurin Soft Capsules Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Midostaurin Soft Capsules Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Midostaurin Soft Capsules Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Midostaurin Soft Capsules Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Midostaurin Soft Capsules Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Midostaurin Soft Capsules Industry Trends
  2. 2.2 Midostaurin Soft Capsules Industry Drivers
  3. 2.3 Midostaurin Soft Capsules Industry Opportunities and Challenges
  4. 2.4 Midostaurin Soft Capsules Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Midostaurin Soft Capsules Revenue (2021-2026)
  2. 3.2 Global Top Players by Midostaurin Soft Capsules Sales (2021-2026)
  3. 3.3 Global Top Players by Midostaurin Soft Capsules Price (2021-2026)
  4. 3.4 Global Midostaurin Soft Capsules Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Midostaurin Soft Capsules Major Company Production Sites & Headquarters
  6. 3.6 Global Midostaurin Soft Capsules Company, Product Type & Application
  7. 3.7 Global Midostaurin Soft Capsules Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Midostaurin Soft Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Midostaurin Soft Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Midostaurin Soft Capsules Tier 1, Tier 2, and Tier 3
4 Midostaurin Soft Capsules Regional Status and Outlook
  1. 4.1 Global Midostaurin Soft Capsules Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Midostaurin Soft Capsules Historic Market Size by Region
  3. 4.2.1 Global Midostaurin Soft Capsules Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Midostaurin Soft Capsules Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Midostaurin Soft Capsules Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Midostaurin Soft Capsules Forecasted Market Size by Region
  7. 4.3.1 Global Midostaurin Soft Capsules Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Midostaurin Soft Capsules Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Midostaurin Soft Capsules Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Midostaurin Soft Capsules by Application
  1. 5.1 Midostaurin Soft Capsules Market by Application
  2. 5.1.1 Systemic Mastocytosis
  3. 5.1.2 Acute Myeloid Leukemia
  4. 5.1.3 Other
  5. 5.2 Global Midostaurin Soft Capsules Market Size by Application
  6. 5.2.1 Global Midostaurin Soft Capsules Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Midostaurin Soft Capsules Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Midostaurin Soft Capsules Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Midostaurin Soft Capsules Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Midostaurin Soft Capsules Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Midostaurin Soft Capsules Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Midostaurin Soft Capsules Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Midostaurin Soft Capsules Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Dr Reddys Laboratories
  2. 6.1.1 Dr Reddys Laboratories Company Information
  3. 6.1.2 Dr Reddys Laboratories Business Overview
  4. 6.1.3 Dr Reddys Laboratories Midostaurin Soft Capsules Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Dr Reddys Laboratories Midostaurin Soft Capsules Product Portfolio
  6. 6.1.5 Dr Reddys Laboratories Recent Developments
  7. 6.2 Glenmark Pharmaceuticals
  8. 6.2.1 Glenmark Pharmaceuticals Company Information
  9. 6.2.2 Glenmark Pharmaceuticals Business Overview
  10. 6.2.3 Glenmark Pharmaceuticals Midostaurin Soft Capsules Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Glenmark Pharmaceuticals Midostaurin Soft Capsules Product Portfolio
  12. 6.2.5 Glenmark Pharmaceuticals Recent Developments
  13. 6.3 Zydus
  14. 6.3.1 Zydus Company Information
  15. 6.3.2 Zydus Business Overview
  16. 6.3.3 Zydus Midostaurin Soft Capsules Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Zydus Midostaurin Soft Capsules Product Portfolio
  18. 6.3.5 Zydus Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Midostaurin Soft Capsules Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Midostaurin Soft Capsules Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Teva Pharmaceuticals
  26. 6.5.1 Teva Pharmaceuticals Company Information
  27. 6.5.2 Teva Pharmaceuticals Business Overview
  28. 6.5.3 Teva Pharmaceuticals Midostaurin Soft Capsules Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Teva Pharmaceuticals Midostaurin Soft Capsules Product Portfolio
  30. 6.5.5 Teva Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Midostaurin Soft Capsules Sales by Country
  2. 7.1.1 North America Midostaurin Soft Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Midostaurin Soft Capsules Sales by Country (2021-2026)
  4. 7.1.3 North America Midostaurin Soft Capsules Sales Forecast by Country (2027-2032)
  5. 7.2 North America Midostaurin Soft Capsules Market Size by Country
  6. 7.2.1 North America Midostaurin Soft Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Midostaurin Soft Capsules Market Size by Country (2021-2026)
  8. 7.2.3 North America Midostaurin Soft Capsules Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Midostaurin Soft Capsules Sales by Country
  2. 8.1.1 Europe Midostaurin Soft Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Midostaurin Soft Capsules Sales by Country (2021-2026)
  4. 8.1.3 Europe Midostaurin Soft Capsules Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Midostaurin Soft Capsules Market Size by Country
  6. 8.2.1 Europe Midostaurin Soft Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Midostaurin Soft Capsules Market Size by Country (2021-2026)
  8. 8.2.3 Europe Midostaurin Soft Capsules Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Midostaurin Soft Capsules Sales by Country
  2. 9.1.1 Asia-Pacific Midostaurin Soft Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Midostaurin Soft Capsules Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Midostaurin Soft Capsules Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Midostaurin Soft Capsules Market Size by Country
  6. 9.2.1 Asia-Pacific Midostaurin Soft Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Midostaurin Soft Capsules Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Midostaurin Soft Capsules Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Midostaurin Soft Capsules Sales by Country
  2. 10.1.1 South America Midostaurin Soft Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Midostaurin Soft Capsules Sales by Country (2021-2026)
  4. 10.1.3 South America Midostaurin Soft Capsules Sales Forecast by Country (2027-2032)
  5. 10.2 South America Midostaurin Soft Capsules Market Size by Country
  6. 10.2.1 South America Midostaurin Soft Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Midostaurin Soft Capsules Market Size by Country (2021-2026)
  8. 10.2.3 South America Midostaurin Soft Capsules Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Midostaurin Soft Capsules Sales by Country
  2. 11.1.1 Middle East and Africa Midostaurin Soft Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Midostaurin Soft Capsules Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Midostaurin Soft Capsules Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Midostaurin Soft Capsules Market Size by Country
  6. 11.2.1 Middle East and Africa Midostaurin Soft Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Midostaurin Soft Capsules Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Midostaurin Soft Capsules Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Midostaurin Soft Capsules Value Chain Analysis
  2. 12.1.1 Midostaurin Soft Capsules Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Midostaurin Soft Capsules Production Mode & Process
  7. 12.2 Midostaurin Soft Capsules Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Midostaurin Soft Capsules Distributors
  10. 12.2.3 Midostaurin Soft Capsules Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst